In this issue:
Lymphocyte count as outcome predictor in chronic HF
Characteristics and outcomes of ALVSD vs. SLVSD in the elderly
Remote telemedical management in ambulatory chronic HF
Erythropoietin for treating anaemia in HF
Omega-3-PUFAs in chronic HF of nonischaemic origin
Risk scores vs. natriuretic peptides for identifying prevalent stage B HF
PROTECT: rolofylline and renal function in acute HF and renal dysfunction
MitraClip® therapy in end-stage systolic HF
Testosterone and HF mortality
Waist circumference, BMI and survival in systolic HF
Please login below to download this issue (PDF)